Jnana Therapeutics tries to take on an untapped class of proteins
Monday, October 15, 2018 - 01:24
in Biology & Nature
With $50 million in funding, the start-up is taking the lead in drugging solute carrier proteins
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via